|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||3.4600 - 3.4600|
|52 Week Range||0.6595 - 6.5500|
|Beta (5Y Monthly)||-2.29|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test. As a result, hospitals and laboratories in the US will be able to use the test for clinical diagnosis of COVID-19. The test is available for immediate distribution into the US market.